Company profile
Sector 10, Inc.
OTC: SECI · Healthcare · Medical - Instruments & Supplies
#1115 of 1,418 Healthcare companies by revenue41st-percentile growth
EA Score
——FH —DQ 49GM —SS 27
v0.1 · 25/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ market scale, Altman-Z
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$16.5M
Employees
2
as of 2026-07-12
Market cap
$31
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$18.5k$18.5k2021
Net income-$16.5M-$16.5M2021
Operating income-$14.7M-$14.7M2021
Total assets$0$02021
Liabilities$10.4M$10.4M2021
Equity-$10.4M-$10.4M2021
Revenue trend
FY2014 – FY2021 · USD
FY14
FY15
FY16
FY17
FY19
FY19
FY20
FY21
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Sector 10, Inc.’s revenue?
Sector 10, Inc. booked $18.5k in FY2021 revenue, growing 0.0% year over year — about the middle of the pack among Healthcare companies we track, at a -89322.9% net margin.
Peers · Healthcare
Skinvisible, Inc.29DSouth American Gold Corp.——THC Farmaceuticals, Inc.——Nanobac Pharmaceuticals, Incorporated——REMSleep Holdings, Inc.19DGemina Laboratories Ltd.——Neighbors
King →Key facts
CEOPericles DeAvila
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersBellevue, WA
ExchangeOTC: SECI
Employees2
IPO date2006-05-10
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.